$6.98+0.00 (+0.03%)
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally.
Lifeward Ltd. in the Healthcare sector is trading at $6.98. Wall Street consensus targets $20.00 (2 analysts), implying a +186.4% move over the next 12 months. The stock is currently 53% below its 52-week high of $15.00, remaining 4.1% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Ger...
Lifeward’s analyst price target has shifted to US$10, prompting a closer look at what is driving this new reference point for the stock. Analysts link the change to updates in their fair value frameworks, which now align the US$10 target with revised assumptions around the company’s future financial profile. As you read on, you will see how this evolving narrative might shape your view of where Lifeward sits today and what to watch next. Analyst Price Targets don't always capture the full...
Lifeward Ltd (LFWD) reports a revenue dip amid supply chain issues but strengthens its position with strategic acquisitions and financing.
William Grant: Thank you, Almog, and thank you for everybody for joining us today. The first quarter of 2026 marked an important strategic milestone for Lifeward as we successfully completed the acquisition of Oratech.
Moby summary of Lifeward Ltd.'s Q1 2026 earnings call
Lifeward (LFWD) delivered earnings and revenue surprises of -1,870.59% and -35.69%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?